720 ILCS 570/207

The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule III if it finds that:

(1) the substance has a potential for misuse less than the substances listed in Schedule I and II;

(2) the substance has currently accepted medical use in treatment in the United States; and

(3) misuse of the substance may lead to moderate or low physiological dependence or high psychological dependence.